[1] MCCAHILL A, WARWICKER J, BOLGER G B, et al.The RACK1 scaffold protein:a dynamic cog in cell response mechanisms [J].Molecular Pharmacology, 2002,62(6):1261-1273.DOI:10.1124/mol.62.6.1261. [2] MOCHLY-ROSEN D, KHANER H, LOPEZ J.Identification of intracellular receptor proteins for activated protein kinase C [J].Biochemistry, 1991,88(9):3997-4000.DOI:10.1073/pnas.88.9.3997. [3] RON D, JIANG Z, YAO L, et al.Coordinated movement of RACK1 with activated βIIPKC [J].The Journal of Biological Chemistry, 1999,274(38):27039-27046.DOI:10.1074/jbc.274.38.27039. [4] STEBBINS E G, MOCHLY-ROSEN D.Binding specificity for RACK1 resides in the V5 region of βII protein kinase C [J].The Journal of Biological Chemistry, 2001,276(32):29644-29650.DOI:10.1074/jbc.M101044200. [5] MAMIDIPUDI V, CARTWRIGHT C A.A novel pro-apoptotic function of RACK1:suppression of Src activity in the intrinsic and Akt pathways [J].Oncogene Article, 2009,28(50):4421-4433.DOI:10.1038/onc.2009.293. [6] NAHAR-GOHAD P, SULTAN H, ESTEBAN Y, et al.RACK1 identified as the PCBP1-interacting protein with a novel functional role on the regulation of human MOR gene expression [J].Journal of Neurochemistry, 2013,124(4):466-477.DOI:10.1111/jnc.12100. [7] KIM E, CLARK A L, KISS A, et al.μ- and κ-opioids induce the differentiation of embryonic stem cells to neural progenitors [J].The Journal of Biological Chemistry, 2006,281(44):33749-33760.DOI:10.1074/jbc.M603862200. [8] BRILLET K, DA CONCEICAO M M, PATTUS F, et al.Bioprocess parameters of cell growth and human mu opioid receptor expression in recombinant Drosophila S2 cell cultures in a bioreactor [J].Bioprocess and Biosystems Engineering, 2006,28(5):291-293.DOI:10.1007/s00449-005-0033-0. [9] HARBURG G C, HALL F S, HARRIST A V, et al.Knockout of the mu opioid receptor enhances the survival of adult-generated hippocampal granule cell neurons [J].Neuroscience, 2007,144(1):77-87.DOI: 10.1016/j.neuroscience.2006.09.018. [10] LENNON F E, MIRZAPOIAZOVA T, MAMBETSARIEV B, et al.Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis [J].Anesthesiology, 2012,116(4):857-867. DOI:10.1097/ALN.0b013e31824babe2. [11] BORTSOV A V, MILLIKAN R C, BELFER I, et al.μ-Opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer [J].Anesthesiology, 2012,116(4):896-902.DOI:10.1097/ALN.0b013e31824b96a1. [12] EGIDY G, JULE S, BOSSE P, et al.Transcription analysis in the MeLiM swine model identifies RACK1 as a potential marker of malignancy for human melanocytic proliferation [J].Molecular Cancer,2008,7:34.DOI:10.1186/1476-4598-7-34. [13] CAO X X, XU J D, XU J W, et al.RACK1 promotes breast carcinoma proliferation and invasion/ metastasis in vitro and in vivo [J].Breast Cancer Research and Treatment, 2010,123(2):375-386.DOI:10.1007/s10549-009-0657-x. [14] NAGASHIO R, SATO Y, MATSUMOTO T, et al.Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas [J].Lung Cancer, 2010,69(1):54-59.DOI:10.1016/j.lungcan.2009.09.015. [15] WANG Z, ZHANG B, JIANG L, et al.RACK1, an excellent predictor for poor clinical outcome in oral squamous carcinoma, similar to Ki67 [J].European Journal of Cancer, 2009,45(3):490-496.DOI:10.1016/j.ejca.2008.11.012. [16] WANG Z, JIANG L, HUANG C, et al.Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma [J].Molecular & Cellular Proteomics, 2008,7(9):1639-1650.DOI:10.1074/mcp.M700520-MCP200. [17] SUBAUSTE M C, VENTURA-HOLMAN T, DU L, et al.RACK1 downregulates levels of the pro-apoptotic protein Fem1b in apoptosis-resistant colon cancer cells [J].Cancer Biology & Therapy, 2009,8(23):2297-2305.DOI:10.4161/cbt.8.23.10262. [18] SHI S, DENG Y Z, ZHAO J S, et al.RACK1 promotes non-small-cell lung cancer tumorigenicity through activating sonic hedgehog signaling pathway [J].The Journal of Biological Chemistry, 2012,287(11):7845-7858.DOI:10.1074/jbc.M111.315416. [19] ZHANG X Y, TANG L Z, REN B G, et al.Interaction of MCM7 and RACK1 for activation of MCM7 and cell growth [J].The American Journal of Pathology, 2013,182(3):796-805.DOI:10.1016/j.ajpath.2012.11.020. [20] SWAMINATHAN G, CARTWRIGHT C A.Rack1 promotes epithelial cell-cell adhesion by regulating E-cadherin endocytosis [J].Oncogene, 2012,31(3):376-389.DOI: 10.1038/onc.2011.242. [21] DENG Y Z, YAO F, LI J J, et al.RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex [J].Gastroenterology,2012,142(4):812-823.DOI:10.1053/j.gastro.2011.12.046. [22] MAMIDIPUDI V, DHILLON N K, PARMAN T, et al.RACK1 inhibits colonic cell growth by regulating Src activity at cell cycle check points [J].Oncogene, 2007,26(20):2914-2924.DOI: 10.1038/sj.onc.1210091. [23] BIRD R J, BAILLIE G S, YARWOOD S J.Interaction with receptor for activated C-kinase 1(RACK1)sensitizes the phosphodiesterase PDE4D5 towards hydrolysis of cAMP and activation by protein kinase C [J].The Biochemical Journal, 2010,432(1):207-216.DOI:10.1042/BJ20101010. [24] DEEVI R K, COX O T, O'CONNOR R.Essential function for PDLIM2 in cell polarization in three-dimensional cultures by feedback regulation of the β1-integrin-RhoA signaling axis [J].Neoplasia, 2014,16(5):422-431.DOI:10.1016/j.neo.2014.04.006. [25] KRÖGER C, LOSCHKE F, SCHWARZ N, et al.Keratins control intercellular adhesion involving PKC-α-mediated desmoplakin phosphorylation [J].The Journal of Cell Biology, 2013,201(5):681-692.DOI:10.1083/jcb.201208162. [26] MYKLEBUST L M, HORVLI O, RAAE A J.RACK1(receptor for activated C-kinase 1)interactions with spectrin repeat elements [J].Journal of Molecular Recognition, 2015,28(1):49-58.DOI:10.1002/jmr.2411. |